Therefore, we evaluated the impact of known AD risk factors (APOE ε4, low education, hypertension, diabetes, dyslipidemia, and obesity) on cognitive trajectories in EOAD and LOAD patients. This evidence concerns the gene APOE and obesity due to melanocortin 4 receptor deficiency.